Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
about
LRP-1: a checkpoint for the extracellular matrix proteolysisCoregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3.Matrix metalloproteinases: old dogs with new tricksHuman trophoblast function during the implantation processExpression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritisHistone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorptionInduction and regulation of matrix metalloproteinase-12 in human airway smooth muscle cells.Matrix Metalloproteinases in Non-Neoplastic Disorders.Gastric biomarkers: a global reviewGlycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunitiesTissue inhibitors of metalloproteinasesRemodelling the extracellular matrix in development and diseaseTIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expressionRole of Nonmuscle Myosin II in Migration of Wharton's Jelly-Derived Mesenchymal Stem Cells.Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTUREMatrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP ComplexesUsing proteomics to uncover extracellular matrix interactions during cardiac remodeling.Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavageActive stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinaseCatalytic activity of human ADAM33Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzymeCell-cell contact activation of fibroblasts increases the expression of matrix metalloproteinasesBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeThe "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancerDifferential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteinsThe comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1Membrane type 1-matrix metalloproteinase/Akt signaling axis modulates TNF-α-induced procoagulant activity and apoptosis in endothelial cellsEctodomain shedding of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, by TIMP-2- and TIMP-3-sensitive proteolysisTissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal.The ADAMTS metalloproteinasesDoxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity.Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse.Potential regulatory relationship between the nested gene DDC8 and its host gene tissue inhibitor of metalloproteinase-2Berberine exposure triggers developmental effects on planarian regeneration.Regulation of gene expression by FSP27 in white and brown adipose tissue.TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2.Identification and characterization of human archaemetzincin-1 and -2, two novel members of a family of metalloproteases widely distributed in Archaea.Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.Low concentrations of transforming growth factor-beta-1 induce tubulogenesis in cultured mammary epithelial cells.
P2860
Q21285122-0242DAC4-4DCB-4175-AE3F-01897E0FA8BBQ24682828-15DF1D8F-1721-4C4B-A9F7-791C4B419D0EQ24795980-018FDC76-AB0D-43C9-AACE-AE077EC06539Q24811501-B76F1C5E-B149-499B-B8BB-89A3786CB65EQ24812237-B023BE94-689A-4726-B26E-F3317CE61FDEQ24816674-D8B95FD3-905C-446A-BC7A-A8769A8ECB52Q25255875-CF3DA2F5-0BB4-4B1A-9A8B-0187E1946214Q26741827-8A09B3F8-5832-4AEA-8142-C52EAD4A4FCCQ26741859-CF96AE7A-283F-4FD4-811B-6DBAC723E00EQ26745510-90289E7F-E8F5-4537-A9E5-639A5A0FD94DQ26829539-FFCC1AF9-B5F8-4222-AB07-790A07ADC6D5Q26864798-29A0ADC7-3BD9-459F-93EF-584C84E907FDQ27303955-E082B7FA-0495-4EF5-9B29-390CF258CF6DQ27307088-48DA8DE9-D19A-4A37-ACFB-A91ADEC99A55Q27678085-1F00E94C-C041-4EEF-B758-BCF06DC840C5Q27680082-411C891F-1C12-4BDF-A0D2-1B6C55DACE1BQ27691351-A34F1FEE-F687-4B38-8A46-5096EA9FA4F0Q28115379-91314035-4AF2-4C34-B498-62E396D4E81AQ28185337-6734573B-F70D-42AA-8220-F9E5B678DFCDQ28191609-D0C41F37-05AA-42D5-A379-2DB2EF4AC9C6Q28235218-32BB4D2A-5CD3-4BD2-A1EA-01B942D47746Q28241965-EE9E2721-4295-40AE-93DC-907A3B3DB5BAQ28288148-9FCC29BC-A470-4FA3-924D-0F75B452BB7EQ28391375-C5E0F8E1-E144-41A9-B705-C2E7364B02D9Q28488743-64E236DB-8DEA-45C8-9F1C-D09FC1165236Q28504860-2960D394-9FD5-4E0C-A8F5-0B0631456B0FQ28542576-736A0BBC-347B-46CC-B8BF-0E831DF13F9CQ28576716-748E3B25-BDE0-4128-B9D3-033B28B36C10Q28583482-7877AA9F-FC8D-4D93-8E6F-F66B485F6982Q29544428-17F2638D-E0FD-4579-A54F-D39A94BF6998Q30489096-78E28D66-9C58-4043-8EC7-A052F1EC33BAQ30499924-36DCA469-0016-493B-96F4-D8A77E7D51A0Q30561811-37A42098-7A25-421F-9A1F-AF9CEBCE5378Q30577702-A47BC9F3-2F11-4CB6-9F6C-967C15129261Q30986230-8AB5DC9F-F780-47F9-886F-5B1BED98A403Q31112275-AE0F0459-44DA-4B60-86B7-BB9EE0E02468Q31808704-4281C90D-17CD-4F82-ABA8-748B11F6C3D7Q33233386-E335EED7-FF7E-40F2-B1E1-F9D40100438BQ33241217-9BD441BE-EB31-40D5-9F79-288465813BDBQ33272861-208AE2AA-7E86-42CF-B9B9-1C160C19A092
P2860
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@ast
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@en
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@nl
type
label
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@ast
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@en
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@nl
prefLabel
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@ast
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@en
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
@nl
P356
P1476
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
@en
P2093
Andrew H Baker
Gillian Murphy
P304
P356
10.1242/JCS.00063
P407
P577
2002-10-01T00:00:00Z